Literature DB >> 5433413

A neurological mutation (msd) of the mouse causing a deficiency of myelin synthesis.

H Meier, A D MacPike.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5433413     DOI: 10.1007/bf00234267

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


× No keyword cloud information.
  19 in total

1.  BRAIN LIPIDS: I. QUANTIFICATION AND FATTY ACID COMPOSITION OF CEREBROSIDE SULFATE IN HUMAN CEREBRAL GRAY AND WHITE MATTER.

Authors:  J S O'BRIEN; D L FILLERUP; J F MEAD
Journal:  J Lipid Res       Date:  1964-01       Impact factor: 5.922

2.  A REVISION OF THE STANDARDIZED GENETIC NOMENCLATURE FOR MICE.

Authors:  M C GREEN; H GRUENEBERG; P HERTWIG; W E HESTON; M F LYON; N N MEDVEDEV; G D SNELL; J STAATS
Journal:  J Hered       Date:  1963 Jul-Aug       Impact factor: 2.645

3.  Changes in the composition of the developing mouse brain during early myelination.

Authors:  L L UZMAN; M K RUMLEY
Journal:  J Neurochem       Date:  1958-12       Impact factor: 5.372

4.  A study of lipid components in brain of the 'Jimpy' mouse, a mutant with myelin deficiency.

Authors:  J L Nussbaum; N Neskovic; P Mandel
Journal:  J Neurochem       Date:  1969-06       Impact factor: 5.372

5.  Fatty acid and lipid composition of the brain of a myelin deficient mutant, the "quaking" mouse.

Authors:  N A Baumann; C M Jacque; S A Pollet; M L Harpin
Journal:  Eur J Biochem       Date:  1968-04

6.  Modification of the schedule of myelination in the rat by early nutritional deprivation.

Authors:  J W Benton; H W Moser; P R Dodge; S Carr
Journal:  Pediatrics       Date:  1966-11       Impact factor: 7.124

7.  Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin.

Authors:  J S O'Brien; E L Sampson
Journal:  J Lipid Res       Date:  1965-10       Impact factor: 5.922

8.  The fatty acid composition of brain sphingolipids: sphingomyelin, ceramide, cerebroside, and cerebroside sulfate.

Authors:  J S O'Brien; G Rouser
Journal:  J Lipid Res       Date:  1964-07       Impact factor: 5.922

9.  Rapid, sensitive spectrophotometric method for quantitative determination of sulfatides.

Authors:  E L Kean
Journal:  J Lipid Res       Date:  1968-05       Impact factor: 5.922

Review 10.  STABILITY OF THE MYELIN MEMBRANE.

Authors:  J S O'BRIEN
Journal:  Science       Date:  1965-03-05       Impact factor: 47.728

View more
  9 in total

Review 1.  Cellular and molecular aspects of myelin protein gene expression.

Authors:  A T Campagnoni; W B Macklin
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

2.  Brain gangliosides of myelin synthesis-deficient mice.

Authors:  M A Bosch; G Rebel; L L Sarliève; N M Neskovic
Journal:  Lipids       Date:  1973-07       Impact factor: 1.880

3.  Liver esterase abnormalities in hereditary neurological diseases of mice.

Authors:  S Tsuji; H Meier
Journal:  Experientia       Date:  1971-03-15

4.  Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation.

Authors:  I Sánchez; L Hassinger; P A Paskevich; H D Shine; R A Nixon
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

5.  Brain nucleic acids and protein in various neurological mutant mice.

Authors:  M Wintzerith; L Sarlieve; A Dierich; P Mandel
Journal:  Neurochem Res       Date:  1980-08       Impact factor: 3.996

6.  Myelin deficiency (md): a neurologic mutant in the Wistar rat.

Authors:  C K Csiza; A de Lahunta
Journal:  Am J Pathol       Date:  1979-04       Impact factor: 4.307

7.  Distribution of central nervous system lesions in beta-mannosidosis.

Authors:  K L Lovell; M Z Jones
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

8.  Mutation in the myelin proteolipid protein gene alters BK and SK channel function in the caudal medulla.

Authors:  Catherine A Mayer; Wendy B Macklin; Nanthawan Avishai; Kannan Balan; Christopher G Wilson; Martha J Miller
Journal:  Respir Physiol Neurobiol       Date:  2009-10-04       Impact factor: 1.931

9.  Clinically relevant intronic splicing enhancer mutation in myelin proteolipid protein leads to progressive microglia and astrocyte activation in white and gray matter regions of the brain.

Authors:  Adam D Bachstetter; Scott J Webster; Linda J Van Eldik; Franca Cambi
Journal:  J Neuroinflammation       Date:  2013-12-05       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.